|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Division of Geriatrics and Nutritional Sciences, Washington University School of Medicine, St. Louis, MO.
2 Presented at the symposium "The Emerging Interplay among Muscle Mitochondrial Function, Nutrition, and Disease,"held at Experimental Biology 2008, San Diego, CA, 5 April 2008 3 Reprints not available. Address correspondence to JO Holloszy, Washington University School of Medicine, 4566 Scott Avenue, Campus Box 8113, St Louis, MO 63110. E-mail: jhollosz{at}dom.wustl.edu.
Patients with type 2 diabetes, insulin-resistant obese individuals, and insulin-resistant offspring of patients with diabetes have
30% less mitochondria in their skeletal muscles than age-matched healthy controls. It has been hypothesized that this "deficiency" of mitochondria mediates insulin resistance by impairing the ability of muscle to oxidize fatty acids (FAs). However, a 30% decrease in mitochondria should not impair the ability of muscle to oxidize FAs because the capacity of muscle to oxidize substrate is far in excess of what is needed to supply energy in the basal state, ie, in resting muscle. In pathologic states in which mitochondrial content/function is so severely impaired as to limit substrate oxidation in resting muscle, glucose uptake and insulin action are actually enhanced. Recent studies have shown that feeding rodents high-fat diets and raising FA concentrations results in muscle insulin resistance despite an increase muscle mitochondria that enhances the capacity for fat oxidation. Furthermore, it was recently shown that skeletal muscle mitochondrial capacity for oxidative phosphorylation in Asian Indians with type 2 diabetes is the same as in nondiabetic Indians and higher than in healthy European Americans. In light of this evidence, it seems highly unlikely that "mitochondrial deficiency" causes muscle insulin resistance.
This article has been cited by other articles:
![]() |
A. Taube, K. Eckardt, and J. Eckel Role of lipid-derived mediators in skeletal muscle insulin resistance Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1004 - E1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Watt and C. R. Bruce No need to sweat: is dieting enough to alleviate insulin resistance in obesity? J. Physiol., November 1, 2009; 587(21): 5001 - 5002. [Full Text] [PDF] |
||||
![]() |
L. Liu, X. Shi, C. S. Choi, G. I. Shulman, K. Klaus, K. S. Nair, G. J. Schwartz, Y. Zhang, I. J. Goldberg, and Y.-H. Yu Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1 Diabetes, November 1, 2009; 58(11): 2516 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R Lanza and K S. Nair Reply to SN Thornton and K Hess Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1476 - 1477. [Full Text] [PDF] |
||||
![]() |
K. R Short Introduction to symposium proceedings: the emerging interplay among muscle mitochondrial function, nutrition, and disease Am. J. Clinical Nutrition, January 1, 2009; 89(1): 453S - 454S. [Full Text] [PDF] |
||||
![]() |
G. P Holloway, A. Bonen, and L. L Spriet Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals Am. J. Clinical Nutrition, January 1, 2009; 89(1): 455S - 462S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R Lanza and K S. Nair Muscle mitochondrial changes with aging and exercise Am. J. Clinical Nutrition, January 1, 2009; 89(1): 467S - 471S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |